Drug Shortage Report for APO-CABERGOLINE

Last updated on 2021-03-02 History
Report ID 41136
Drug Identification Number 02455897
Brand name APO-CABERGOLINE
Common or Proper name CABERGOLINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) CABERGOLINE
Strength(s) 0.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 8 BTL
ATC code G02CB
ATC description OTHER GYNECOLOGICALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-02-26
Estimated end date Unknown
Actual end date 2021-03-01
Shortage status Resolved
Updated date 2021-03-02
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v25 2021-03-02 English Compare
v24 2021-03-01 French Compare
v23 2021-03-01 English Compare
v22 2020-03-30 French Compare
v21 2020-03-30 English Compare
v20 2020-02-18 French Compare
v19 2020-02-18 English Compare
v18 2019-10-07 French Compare
v17 2019-10-07 English Compare
v16 2019-09-09 French Compare
v15 2019-09-09 English Compare
v14 2019-07-12 French Compare
v13 2019-07-12 English Compare
v12 2019-04-29 French Compare
v11 2019-04-29 English Compare
v10 2019-04-22 French Compare
v9 2019-04-22 English Compare
v8 2019-03-15 French Compare
v7 2019-03-15 English Compare
v6 2018-11-30 French Compare

Showing 1 to 20 of 25